Global Swine Autogenous Vaccines Market Growth 2025-2031
The global Swine Autogenous Vaccines market size is predicted to grow from US$ 428 million in 2025 to US$ 601 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.
Swine autogenous vaccines are vaccines prepared using pathogen isolates from pig herds themselves, targeting specific pathogens or diseases in pig farms. The production process of these vaccines typically includes isolating pathogens from sick pigs, purifying and culturing them, and preparing vaccine antigens. Swine autogenous vaccines offer high degrees of specificity and adaptability, enabling more effective responses to specific disease issues in pig farms. Since the vaccine antigens are derived from pathogens within the pig herd, swine autogenous vaccines have unique advantages in stimulating the immune response of pigs, providing more effective immune protection.
United States market for Swine Autogenous Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Swine Autogenous Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Swine Autogenous Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Swine Autogenous Vaccines players cover San Vet, Bimeda Biologicals, Vaxxinova, Merck Animal Health, Boehringer Ingelheim, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Swine Autogenous Vaccines Industry Forecast” looks at past sales and reviews total world Swine Autogenous Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Swine Autogenous Vaccines sales for 2025 through 2031. With Swine Autogenous Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Swine Autogenous Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Swine Autogenous Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Swine Autogenous Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Swine Autogenous Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Swine Autogenous Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Swine Autogenous Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Swine Autogenous Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Swine Autogenous Vaccines market?
What factors are driving Swine Autogenous Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Swine Autogenous Vaccines market opportunities vary by end market size?
How does Swine Autogenous Vaccines break out by Type, by Application?
Swine autogenous vaccines are vaccines prepared using pathogen isolates from pig herds themselves, targeting specific pathogens or diseases in pig farms. The production process of these vaccines typically includes isolating pathogens from sick pigs, purifying and culturing them, and preparing vaccine antigens. Swine autogenous vaccines offer high degrees of specificity and adaptability, enabling more effective responses to specific disease issues in pig farms. Since the vaccine antigens are derived from pathogens within the pig herd, swine autogenous vaccines have unique advantages in stimulating the immune response of pigs, providing more effective immune protection.
United States market for Swine Autogenous Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Swine Autogenous Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Swine Autogenous Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Swine Autogenous Vaccines players cover San Vet, Bimeda Biologicals, Vaxxinova, Merck Animal Health, Boehringer Ingelheim, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Swine Autogenous Vaccines Industry Forecast” looks at past sales and reviews total world Swine Autogenous Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Swine Autogenous Vaccines sales for 2025 through 2031. With Swine Autogenous Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Swine Autogenous Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Swine Autogenous Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Swine Autogenous Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Swine Autogenous Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Swine Autogenous Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Swine Autogenous Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Swine Autogenous Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Respiratory System Vaccines
- Intestinal System Vaccines
- Reproductive System Vaccines
- Others
- Government Bidding
- Market Sales
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- San Vet
- Bimeda Biologicals
- Vaxxinova
- Merck Animal Health
- Boehringer Ingelheim
- Phibro Animal Health Corporation
- Dopharma
- Ceva Biovac
What is the 10-year outlook for the global Swine Autogenous Vaccines market?
What factors are driving Swine Autogenous Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Swine Autogenous Vaccines market opportunities vary by end market size?
How does Swine Autogenous Vaccines break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Swine Autogenous Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Swine Autogenous Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Swine Autogenous Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Swine Autogenous Vaccines Segment by Type
2.2.1 Respiratory System Vaccines
2.2.2 Intestinal System Vaccines
2.2.3 Reproductive System Vaccines
2.2.4 Others
2.3 Swine Autogenous Vaccines Sales by Type
2.3.1 Global Swine Autogenous Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Swine Autogenous Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Swine Autogenous Vaccines Sale Price by Type (2020-2025)
2.4 Swine Autogenous Vaccines Segment by Application
2.4.1 Government Bidding
2.4.2 Market Sales
2.5 Swine Autogenous Vaccines Sales by Application
2.5.1 Global Swine Autogenous Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Swine Autogenous Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Swine Autogenous Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Swine Autogenous Vaccines Breakdown Data by Company
3.1.1 Global Swine Autogenous Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Swine Autogenous Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Swine Autogenous Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Swine Autogenous Vaccines Revenue by Company (2020-2025)
3.2.2 Global Swine Autogenous Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Swine Autogenous Vaccines Sale Price by Company
3.4 Key Manufacturers Swine Autogenous Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Swine Autogenous Vaccines Product Location Distribution
3.4.2 Players Swine Autogenous Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SWINE AUTOGENOUS VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Swine Autogenous Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Swine Autogenous Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Swine Autogenous Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Swine Autogenous Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Swine Autogenous Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Swine Autogenous Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Swine Autogenous Vaccines Sales Growth
4.4 APAC Swine Autogenous Vaccines Sales Growth
4.5 Europe Swine Autogenous Vaccines Sales Growth
4.6 Middle East & Africa Swine Autogenous Vaccines Sales Growth
5 AMERICAS
5.1 Americas Swine Autogenous Vaccines Sales by Country
5.1.1 Americas Swine Autogenous Vaccines Sales by Country (2020-2025)
5.1.2 Americas Swine Autogenous Vaccines Revenue by Country (2020-2025)
5.2 Americas Swine Autogenous Vaccines Sales by Type (2020-2025)
5.3 Americas Swine Autogenous Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Swine Autogenous Vaccines Sales by Region
6.1.1 APAC Swine Autogenous Vaccines Sales by Region (2020-2025)
6.1.2 APAC Swine Autogenous Vaccines Revenue by Region (2020-2025)
6.2 APAC Swine Autogenous Vaccines Sales by Type (2020-2025)
6.3 APAC Swine Autogenous Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Swine Autogenous Vaccines by Country
7.1.1 Europe Swine Autogenous Vaccines Sales by Country (2020-2025)
7.1.2 Europe Swine Autogenous Vaccines Revenue by Country (2020-2025)
7.2 Europe Swine Autogenous Vaccines Sales by Type (2020-2025)
7.3 Europe Swine Autogenous Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Swine Autogenous Vaccines by Country
8.1.1 Middle East & Africa Swine Autogenous Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Swine Autogenous Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Swine Autogenous Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Swine Autogenous Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Swine Autogenous Vaccines
10.3 Manufacturing Process Analysis of Swine Autogenous Vaccines
10.4 Industry Chain Structure of Swine Autogenous Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Swine Autogenous Vaccines Distributors
11.3 Swine Autogenous Vaccines Customer
12 WORLD FORECAST REVIEW FOR SWINE AUTOGENOUS VACCINES BY GEOGRAPHIC REGION
12.1 Global Swine Autogenous Vaccines Market Size Forecast by Region
12.1.1 Global Swine Autogenous Vaccines Forecast by Region (2026-2031)
12.1.2 Global Swine Autogenous Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Swine Autogenous Vaccines Forecast by Type (2026-2031)
12.7 Global Swine Autogenous Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 San Vet
13.1.1 San Vet Company Information
13.1.2 San Vet Swine Autogenous Vaccines Product Portfolios and Specifications
13.1.3 San Vet Swine Autogenous Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 San Vet Main Business Overview
13.1.5 San Vet Latest Developments
13.2 Bimeda Biologicals
13.2.1 Bimeda Biologicals Company Information
13.2.2 Bimeda Biologicals Swine Autogenous Vaccines Product Portfolios and Specifications
13.2.3 Bimeda Biologicals Swine Autogenous Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bimeda Biologicals Main Business Overview
13.2.5 Bimeda Biologicals Latest Developments
13.3 Vaxxinova
13.3.1 Vaxxinova Company Information
13.3.2 Vaxxinova Swine Autogenous Vaccines Product Portfolios and Specifications
13.3.3 Vaxxinova Swine Autogenous Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Vaxxinova Main Business Overview
13.3.5 Vaxxinova Latest Developments
13.4 Merck Animal Health
13.4.1 Merck Animal Health Company Information
13.4.2 Merck Animal Health Swine Autogenous Vaccines Product Portfolios and Specifications
13.4.3 Merck Animal Health Swine Autogenous Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Merck Animal Health Main Business Overview
13.4.5 Merck Animal Health Latest Developments
13.5 Boehringer Ingelheim
13.5.1 Boehringer Ingelheim Company Information
13.5.2 Boehringer Ingelheim Swine Autogenous Vaccines Product Portfolios and Specifications
13.5.3 Boehringer Ingelheim Swine Autogenous Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Boehringer Ingelheim Main Business Overview
13.5.5 Boehringer Ingelheim Latest Developments
13.6 Phibro Animal Health Corporation
13.6.1 Phibro Animal Health Corporation Company Information
13.6.2 Phibro Animal Health Corporation Swine Autogenous Vaccines Product Portfolios and Specifications
13.6.3 Phibro Animal Health Corporation Swine Autogenous Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Phibro Animal Health Corporation Main Business Overview
13.6.5 Phibro Animal Health Corporation Latest Developments
13.7 Dopharma
13.7.1 Dopharma Company Information
13.7.2 Dopharma Swine Autogenous Vaccines Product Portfolios and Specifications
13.7.3 Dopharma Swine Autogenous Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Dopharma Main Business Overview
13.7.5 Dopharma Latest Developments
13.8 Ceva Biovac
13.8.1 Ceva Biovac Company Information
13.8.2 Ceva Biovac Swine Autogenous Vaccines Product Portfolios and Specifications
13.8.3 Ceva Biovac Swine Autogenous Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Ceva Biovac Main Business Overview
13.8.5 Ceva Biovac Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Swine Autogenous Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Swine Autogenous Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Swine Autogenous Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Swine Autogenous Vaccines Segment by Type
2.2.1 Respiratory System Vaccines
2.2.2 Intestinal System Vaccines
2.2.3 Reproductive System Vaccines
2.2.4 Others
2.3 Swine Autogenous Vaccines Sales by Type
2.3.1 Global Swine Autogenous Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Swine Autogenous Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Swine Autogenous Vaccines Sale Price by Type (2020-2025)
2.4 Swine Autogenous Vaccines Segment by Application
2.4.1 Government Bidding
2.4.2 Market Sales
2.5 Swine Autogenous Vaccines Sales by Application
2.5.1 Global Swine Autogenous Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Swine Autogenous Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Swine Autogenous Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Swine Autogenous Vaccines Breakdown Data by Company
3.1.1 Global Swine Autogenous Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Swine Autogenous Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Swine Autogenous Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Swine Autogenous Vaccines Revenue by Company (2020-2025)
3.2.2 Global Swine Autogenous Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Swine Autogenous Vaccines Sale Price by Company
3.4 Key Manufacturers Swine Autogenous Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Swine Autogenous Vaccines Product Location Distribution
3.4.2 Players Swine Autogenous Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SWINE AUTOGENOUS VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Swine Autogenous Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Swine Autogenous Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Swine Autogenous Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Swine Autogenous Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Swine Autogenous Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Swine Autogenous Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Swine Autogenous Vaccines Sales Growth
4.4 APAC Swine Autogenous Vaccines Sales Growth
4.5 Europe Swine Autogenous Vaccines Sales Growth
4.6 Middle East & Africa Swine Autogenous Vaccines Sales Growth
5 AMERICAS
5.1 Americas Swine Autogenous Vaccines Sales by Country
5.1.1 Americas Swine Autogenous Vaccines Sales by Country (2020-2025)
5.1.2 Americas Swine Autogenous Vaccines Revenue by Country (2020-2025)
5.2 Americas Swine Autogenous Vaccines Sales by Type (2020-2025)
5.3 Americas Swine Autogenous Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Swine Autogenous Vaccines Sales by Region
6.1.1 APAC Swine Autogenous Vaccines Sales by Region (2020-2025)
6.1.2 APAC Swine Autogenous Vaccines Revenue by Region (2020-2025)
6.2 APAC Swine Autogenous Vaccines Sales by Type (2020-2025)
6.3 APAC Swine Autogenous Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Swine Autogenous Vaccines by Country
7.1.1 Europe Swine Autogenous Vaccines Sales by Country (2020-2025)
7.1.2 Europe Swine Autogenous Vaccines Revenue by Country (2020-2025)
7.2 Europe Swine Autogenous Vaccines Sales by Type (2020-2025)
7.3 Europe Swine Autogenous Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Swine Autogenous Vaccines by Country
8.1.1 Middle East & Africa Swine Autogenous Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Swine Autogenous Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Swine Autogenous Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Swine Autogenous Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Swine Autogenous Vaccines
10.3 Manufacturing Process Analysis of Swine Autogenous Vaccines
10.4 Industry Chain Structure of Swine Autogenous Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Swine Autogenous Vaccines Distributors
11.3 Swine Autogenous Vaccines Customer
12 WORLD FORECAST REVIEW FOR SWINE AUTOGENOUS VACCINES BY GEOGRAPHIC REGION
12.1 Global Swine Autogenous Vaccines Market Size Forecast by Region
12.1.1 Global Swine Autogenous Vaccines Forecast by Region (2026-2031)
12.1.2 Global Swine Autogenous Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Swine Autogenous Vaccines Forecast by Type (2026-2031)
12.7 Global Swine Autogenous Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 San Vet
13.1.1 San Vet Company Information
13.1.2 San Vet Swine Autogenous Vaccines Product Portfolios and Specifications
13.1.3 San Vet Swine Autogenous Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 San Vet Main Business Overview
13.1.5 San Vet Latest Developments
13.2 Bimeda Biologicals
13.2.1 Bimeda Biologicals Company Information
13.2.2 Bimeda Biologicals Swine Autogenous Vaccines Product Portfolios and Specifications
13.2.3 Bimeda Biologicals Swine Autogenous Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bimeda Biologicals Main Business Overview
13.2.5 Bimeda Biologicals Latest Developments
13.3 Vaxxinova
13.3.1 Vaxxinova Company Information
13.3.2 Vaxxinova Swine Autogenous Vaccines Product Portfolios and Specifications
13.3.3 Vaxxinova Swine Autogenous Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Vaxxinova Main Business Overview
13.3.5 Vaxxinova Latest Developments
13.4 Merck Animal Health
13.4.1 Merck Animal Health Company Information
13.4.2 Merck Animal Health Swine Autogenous Vaccines Product Portfolios and Specifications
13.4.3 Merck Animal Health Swine Autogenous Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Merck Animal Health Main Business Overview
13.4.5 Merck Animal Health Latest Developments
13.5 Boehringer Ingelheim
13.5.1 Boehringer Ingelheim Company Information
13.5.2 Boehringer Ingelheim Swine Autogenous Vaccines Product Portfolios and Specifications
13.5.3 Boehringer Ingelheim Swine Autogenous Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Boehringer Ingelheim Main Business Overview
13.5.5 Boehringer Ingelheim Latest Developments
13.6 Phibro Animal Health Corporation
13.6.1 Phibro Animal Health Corporation Company Information
13.6.2 Phibro Animal Health Corporation Swine Autogenous Vaccines Product Portfolios and Specifications
13.6.3 Phibro Animal Health Corporation Swine Autogenous Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Phibro Animal Health Corporation Main Business Overview
13.6.5 Phibro Animal Health Corporation Latest Developments
13.7 Dopharma
13.7.1 Dopharma Company Information
13.7.2 Dopharma Swine Autogenous Vaccines Product Portfolios and Specifications
13.7.3 Dopharma Swine Autogenous Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Dopharma Main Business Overview
13.7.5 Dopharma Latest Developments
13.8 Ceva Biovac
13.8.1 Ceva Biovac Company Information
13.8.2 Ceva Biovac Swine Autogenous Vaccines Product Portfolios and Specifications
13.8.3 Ceva Biovac Swine Autogenous Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Ceva Biovac Main Business Overview
13.8.5 Ceva Biovac Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Swine Autogenous Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Swine Autogenous Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Respiratory System Vaccines
Table 4. Major Players of Intestinal System Vaccines
Table 5. Major Players of Reproductive System Vaccines
Table 6. Major Players of Others
Table 7. Global Swine Autogenous Vaccines Sales by Type (2020-2025) & (K Units)
Table 8. Global Swine Autogenous Vaccines Sales Market Share by Type (2020-2025)
Table 9. Global Swine Autogenous Vaccines Revenue by Type (2020-2025) & ($ million)
Table 10. Global Swine Autogenous Vaccines Revenue Market Share by Type (2020-2025)
Table 11. Global Swine Autogenous Vaccines Sale Price by Type (2020-2025) & (US$/Unit)
Table 12. Global Swine Autogenous Vaccines Sale by Application (2020-2025) & (K Units)
Table 13. Global Swine Autogenous Vaccines Sale Market Share by Application (2020-2025)
Table 14. Global Swine Autogenous Vaccines Revenue by Application (2020-2025) & ($ million)
Table 15. Global Swine Autogenous Vaccines Revenue Market Share by Application (2020-2025)
Table 16. Global Swine Autogenous Vaccines Sale Price by Application (2020-2025) & (US$/Unit)
Table 17. Global Swine Autogenous Vaccines Sales by Company (2020-2025) & (K Units)
Table 18. Global Swine Autogenous Vaccines Sales Market Share by Company (2020-2025)
Table 19. Global Swine Autogenous Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Swine Autogenous Vaccines Revenue Market Share by Company (2020-2025)
Table 21. Global Swine Autogenous Vaccines Sale Price by Company (2020-2025) & (US$/Unit)
Table 22. Key Manufacturers Swine Autogenous Vaccines Producing Area Distribution and Sales Area
Table 23. Players Swine Autogenous Vaccines Products Offered
Table 24. Swine Autogenous Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Swine Autogenous Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Swine Autogenous Vaccines Sales Market Share Geographic Region (2020-2025)
Table 29. Global Swine Autogenous Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Swine Autogenous Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Swine Autogenous Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Swine Autogenous Vaccines Sales Market Share by Country/Region (2020-2025)
Table 33. Global Swine Autogenous Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Swine Autogenous Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Swine Autogenous Vaccines Sales by Country (2020-2025) & (K Units)
Table 36. Americas Swine Autogenous Vaccines Sales Market Share by Country (2020-2025)
Table 37. Americas Swine Autogenous Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Swine Autogenous Vaccines Sales by Type (2020-2025) & (K Units)
Table 39. Americas Swine Autogenous Vaccines Sales by Application (2020-2025) & (K Units)
Table 40. APAC Swine Autogenous Vaccines Sales by Region (2020-2025) & (K Units)
Table 41. APAC Swine Autogenous Vaccines Sales Market Share by Region (2020-2025)
Table 42. APAC Swine Autogenous Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Swine Autogenous Vaccines Sales by Type (2020-2025) & (K Units)
Table 44. APAC Swine Autogenous Vaccines Sales by Application (2020-2025) & (K Units)
Table 45. Europe Swine Autogenous Vaccines Sales by Country (2020-2025) & (K Units)
Table 46. Europe Swine Autogenous Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Swine Autogenous Vaccines Sales by Type (2020-2025) & (K Units)
Table 48. Europe Swine Autogenous Vaccines Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Swine Autogenous Vaccines Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Swine Autogenous Vaccines Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Swine Autogenous Vaccines Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Swine Autogenous Vaccines Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Swine Autogenous Vaccines
Table 54. Key Market Challenges & Risks of Swine Autogenous Vaccines
Table 55. Key Industry Trends of Swine Autogenous Vaccines
Table 56. Swine Autogenous Vaccines Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Swine Autogenous Vaccines Distributors List
Table 59. Swine Autogenous Vaccines Customer List
Table 60. Global Swine Autogenous Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Swine Autogenous Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Swine Autogenous Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Swine Autogenous Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Swine Autogenous Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Swine Autogenous Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Swine Autogenous Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Swine Autogenous Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Swine Autogenous Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Swine Autogenous Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Swine Autogenous Vaccines Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Swine Autogenous Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Swine Autogenous Vaccines Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Swine Autogenous Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. San Vet Basic Information, Swine Autogenous Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 75. San Vet Swine Autogenous Vaccines Product Portfolios and Specifications
Table 76. San Vet Swine Autogenous Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 77. San Vet Main Business
Table 78. San Vet Latest Developments
Table 79. Bimeda Biologicals Basic Information, Swine Autogenous Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 80. Bimeda Biologicals Swine Autogenous Vaccines Product Portfolios and Specifications
Table 81. Bimeda Biologicals Swine Autogenous Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 82. Bimeda Biologicals Main Business
Table 83. Bimeda Biologicals Latest Developments
Table 84. Vaxxinova Basic Information, Swine Autogenous Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 85. Vaxxinova Swine Autogenous Vaccines Product Portfolios and Specifications
Table 86. Vaxxinova Swine Autogenous Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 87. Vaxxinova Main Business
Table 88. Vaxxinova Latest Developments
Table 89. Merck Animal Health Basic Information, Swine Autogenous Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 90. Merck Animal Health Swine Autogenous Vaccines Product Portfolios and Specifications
Table 91. Merck Animal Health Swine Autogenous Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 92. Merck Animal Health Main Business
Table 93. Merck Animal Health Latest Developments
Table 94. Boehringer Ingelheim Basic Information, Swine Autogenous Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. Boehringer Ingelheim Swine Autogenous Vaccines Product Portfolios and Specifications
Table 96. Boehringer Ingelheim Swine Autogenous Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 97. Boehringer Ingelheim Main Business
Table 98. Boehringer Ingelheim Latest Developments
Table 99. Phibro Animal Health Corporation Basic Information, Swine Autogenous Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. Phibro Animal Health Corporation Swine Autogenous Vaccines Product Portfolios and Specifications
Table 101. Phibro Animal Health Corporation Swine Autogenous Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 102. Phibro Animal Health Corporation Main Business
Table 103. Phibro Animal Health Corporation Latest Developments
Table 104. Dopharma Basic Information, Swine Autogenous Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 105. Dopharma Swine Autogenous Vaccines Product Portfolios and Specifications
Table 106. Dopharma Swine Autogenous Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 107. Dopharma Main Business
Table 108. Dopharma Latest Developments
Table 109. Ceva Biovac Basic Information, Swine Autogenous Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 110. Ceva Biovac Swine Autogenous Vaccines Product Portfolios and Specifications
Table 111. Ceva Biovac Swine Autogenous Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 112. Ceva Biovac Main Business
Table 113. Ceva Biovac Latest Developments
Table 1. Swine Autogenous Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Swine Autogenous Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Respiratory System Vaccines
Table 4. Major Players of Intestinal System Vaccines
Table 5. Major Players of Reproductive System Vaccines
Table 6. Major Players of Others
Table 7. Global Swine Autogenous Vaccines Sales by Type (2020-2025) & (K Units)
Table 8. Global Swine Autogenous Vaccines Sales Market Share by Type (2020-2025)
Table 9. Global Swine Autogenous Vaccines Revenue by Type (2020-2025) & ($ million)
Table 10. Global Swine Autogenous Vaccines Revenue Market Share by Type (2020-2025)
Table 11. Global Swine Autogenous Vaccines Sale Price by Type (2020-2025) & (US$/Unit)
Table 12. Global Swine Autogenous Vaccines Sale by Application (2020-2025) & (K Units)
Table 13. Global Swine Autogenous Vaccines Sale Market Share by Application (2020-2025)
Table 14. Global Swine Autogenous Vaccines Revenue by Application (2020-2025) & ($ million)
Table 15. Global Swine Autogenous Vaccines Revenue Market Share by Application (2020-2025)
Table 16. Global Swine Autogenous Vaccines Sale Price by Application (2020-2025) & (US$/Unit)
Table 17. Global Swine Autogenous Vaccines Sales by Company (2020-2025) & (K Units)
Table 18. Global Swine Autogenous Vaccines Sales Market Share by Company (2020-2025)
Table 19. Global Swine Autogenous Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Swine Autogenous Vaccines Revenue Market Share by Company (2020-2025)
Table 21. Global Swine Autogenous Vaccines Sale Price by Company (2020-2025) & (US$/Unit)
Table 22. Key Manufacturers Swine Autogenous Vaccines Producing Area Distribution and Sales Area
Table 23. Players Swine Autogenous Vaccines Products Offered
Table 24. Swine Autogenous Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Swine Autogenous Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Swine Autogenous Vaccines Sales Market Share Geographic Region (2020-2025)
Table 29. Global Swine Autogenous Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Swine Autogenous Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Swine Autogenous Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Swine Autogenous Vaccines Sales Market Share by Country/Region (2020-2025)
Table 33. Global Swine Autogenous Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Swine Autogenous Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Swine Autogenous Vaccines Sales by Country (2020-2025) & (K Units)
Table 36. Americas Swine Autogenous Vaccines Sales Market Share by Country (2020-2025)
Table 37. Americas Swine Autogenous Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Swine Autogenous Vaccines Sales by Type (2020-2025) & (K Units)
Table 39. Americas Swine Autogenous Vaccines Sales by Application (2020-2025) & (K Units)
Table 40. APAC Swine Autogenous Vaccines Sales by Region (2020-2025) & (K Units)
Table 41. APAC Swine Autogenous Vaccines Sales Market Share by Region (2020-2025)
Table 42. APAC Swine Autogenous Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Swine Autogenous Vaccines Sales by Type (2020-2025) & (K Units)
Table 44. APAC Swine Autogenous Vaccines Sales by Application (2020-2025) & (K Units)
Table 45. Europe Swine Autogenous Vaccines Sales by Country (2020-2025) & (K Units)
Table 46. Europe Swine Autogenous Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Swine Autogenous Vaccines Sales by Type (2020-2025) & (K Units)
Table 48. Europe Swine Autogenous Vaccines Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Swine Autogenous Vaccines Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Swine Autogenous Vaccines Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Swine Autogenous Vaccines Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Swine Autogenous Vaccines Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Swine Autogenous Vaccines
Table 54. Key Market Challenges & Risks of Swine Autogenous Vaccines
Table 55. Key Industry Trends of Swine Autogenous Vaccines
Table 56. Swine Autogenous Vaccines Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Swine Autogenous Vaccines Distributors List
Table 59. Swine Autogenous Vaccines Customer List
Table 60. Global Swine Autogenous Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Swine Autogenous Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Swine Autogenous Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Swine Autogenous Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Swine Autogenous Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Swine Autogenous Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Swine Autogenous Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Swine Autogenous Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Swine Autogenous Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Swine Autogenous Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Swine Autogenous Vaccines Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Swine Autogenous Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Swine Autogenous Vaccines Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Swine Autogenous Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. San Vet Basic Information, Swine Autogenous Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 75. San Vet Swine Autogenous Vaccines Product Portfolios and Specifications
Table 76. San Vet Swine Autogenous Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 77. San Vet Main Business
Table 78. San Vet Latest Developments
Table 79. Bimeda Biologicals Basic Information, Swine Autogenous Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 80. Bimeda Biologicals Swine Autogenous Vaccines Product Portfolios and Specifications
Table 81. Bimeda Biologicals Swine Autogenous Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 82. Bimeda Biologicals Main Business
Table 83. Bimeda Biologicals Latest Developments
Table 84. Vaxxinova Basic Information, Swine Autogenous Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 85. Vaxxinova Swine Autogenous Vaccines Product Portfolios and Specifications
Table 86. Vaxxinova Swine Autogenous Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 87. Vaxxinova Main Business
Table 88. Vaxxinova Latest Developments
Table 89. Merck Animal Health Basic Information, Swine Autogenous Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 90. Merck Animal Health Swine Autogenous Vaccines Product Portfolios and Specifications
Table 91. Merck Animal Health Swine Autogenous Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 92. Merck Animal Health Main Business
Table 93. Merck Animal Health Latest Developments
Table 94. Boehringer Ingelheim Basic Information, Swine Autogenous Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. Boehringer Ingelheim Swine Autogenous Vaccines Product Portfolios and Specifications
Table 96. Boehringer Ingelheim Swine Autogenous Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 97. Boehringer Ingelheim Main Business
Table 98. Boehringer Ingelheim Latest Developments
Table 99. Phibro Animal Health Corporation Basic Information, Swine Autogenous Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. Phibro Animal Health Corporation Swine Autogenous Vaccines Product Portfolios and Specifications
Table 101. Phibro Animal Health Corporation Swine Autogenous Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 102. Phibro Animal Health Corporation Main Business
Table 103. Phibro Animal Health Corporation Latest Developments
Table 104. Dopharma Basic Information, Swine Autogenous Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 105. Dopharma Swine Autogenous Vaccines Product Portfolios and Specifications
Table 106. Dopharma Swine Autogenous Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 107. Dopharma Main Business
Table 108. Dopharma Latest Developments
Table 109. Ceva Biovac Basic Information, Swine Autogenous Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 110. Ceva Biovac Swine Autogenous Vaccines Product Portfolios and Specifications
Table 111. Ceva Biovac Swine Autogenous Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 112. Ceva Biovac Main Business
Table 113. Ceva Biovac Latest Developments
LIST OF FIGURES
Figure 1. Picture of Swine Autogenous Vaccines
Figure 2. Swine Autogenous Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Swine Autogenous Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Swine Autogenous Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Swine Autogenous Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Swine Autogenous Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Swine Autogenous Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Respiratory System Vaccines
Figure 12. Product Picture of Intestinal System Vaccines
Figure 13. Product Picture of Reproductive System Vaccines
Figure 14. Product Picture of Others
Figure 15. Global Swine Autogenous Vaccines Sales Market Share by Type in 2025
Figure 16. Global Swine Autogenous Vaccines Revenue Market Share by Type (2020-2025)
Figure 17. Swine Autogenous Vaccines Consumed in Government Bidding
Figure 18. Global Swine Autogenous Vaccines Market: Government Bidding (2020-2025) & (K Units)
Figure 19. Swine Autogenous Vaccines Consumed in Market Sales
Figure 20. Global Swine Autogenous Vaccines Market: Market Sales (2020-2025) & (K Units)
Figure 21. Global Swine Autogenous Vaccines Sale Market Share by Application (2024)
Figure 22. Global Swine Autogenous Vaccines Revenue Market Share by Application in 2025
Figure 23. Swine Autogenous Vaccines Sales by Company in 2025 (K Units)
Figure 24. Global Swine Autogenous Vaccines Sales Market Share by Company in 2025
Figure 25. Swine Autogenous Vaccines Revenue by Company in 2025 ($ millions)
Figure 26. Global Swine Autogenous Vaccines Revenue Market Share by Company in 2025
Figure 27. Global Swine Autogenous Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Swine Autogenous Vaccines Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Swine Autogenous Vaccines Sales 2020-2025 (K Units)
Figure 30. Americas Swine Autogenous Vaccines Revenue 2020-2025 ($ millions)
Figure 31. APAC Swine Autogenous Vaccines Sales 2020-2025 (K Units)
Figure 32. APAC Swine Autogenous Vaccines Revenue 2020-2025 ($ millions)
Figure 33. Europe Swine Autogenous Vaccines Sales 2020-2025 (K Units)
Figure 34. Europe Swine Autogenous Vaccines Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Swine Autogenous Vaccines Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Swine Autogenous Vaccines Revenue 2020-2025 ($ millions)
Figure 37. Americas Swine Autogenous Vaccines Sales Market Share by Country in 2025
Figure 38. Americas Swine Autogenous Vaccines Revenue Market Share by Country (2020-2025)
Figure 39. Americas Swine Autogenous Vaccines Sales Market Share by Type (2020-2025)
Figure 40. Americas Swine Autogenous Vaccines Sales Market Share by Application (2020-2025)
Figure 41. United States Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Swine Autogenous Vaccines Sales Market Share by Region in 2025
Figure 46. APAC Swine Autogenous Vaccines Revenue Market Share by Region (2020-2025)
Figure 47. APAC Swine Autogenous Vaccines Sales Market Share by Type (2020-2025)
Figure 48. APAC Swine Autogenous Vaccines Sales Market Share by Application (2020-2025)
Figure 49. China Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. India Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Swine Autogenous Vaccines Sales Market Share by Country in 2025
Figure 57. Europe Swine Autogenous Vaccines Revenue Market Share by Country (2020-2025)
Figure 58. Europe Swine Autogenous Vaccines Sales Market Share by Type (2020-2025)
Figure 59. Europe Swine Autogenous Vaccines Sales Market Share by Application (2020-2025)
Figure 60. Germany Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61. France Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Swine Autogenous Vaccines Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Swine Autogenous Vaccines Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Swine Autogenous Vaccines Sales Market Share by Application (2020-2025)
Figure 68. Egypt Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Swine Autogenous Vaccines in 2025
Figure 74. Manufacturing Process Analysis of Swine Autogenous Vaccines
Figure 75. Industry Chain Structure of Swine Autogenous Vaccines
Figure 76. Channels of Distribution
Figure 77. Global Swine Autogenous Vaccines Sales Market Forecast by Region (2026-2031)
Figure 78. Global Swine Autogenous Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Swine Autogenous Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Swine Autogenous Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Swine Autogenous Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Swine Autogenous Vaccines Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Swine Autogenous Vaccines
Figure 2. Swine Autogenous Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Swine Autogenous Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Swine Autogenous Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Swine Autogenous Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Swine Autogenous Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Swine Autogenous Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Respiratory System Vaccines
Figure 12. Product Picture of Intestinal System Vaccines
Figure 13. Product Picture of Reproductive System Vaccines
Figure 14. Product Picture of Others
Figure 15. Global Swine Autogenous Vaccines Sales Market Share by Type in 2025
Figure 16. Global Swine Autogenous Vaccines Revenue Market Share by Type (2020-2025)
Figure 17. Swine Autogenous Vaccines Consumed in Government Bidding
Figure 18. Global Swine Autogenous Vaccines Market: Government Bidding (2020-2025) & (K Units)
Figure 19. Swine Autogenous Vaccines Consumed in Market Sales
Figure 20. Global Swine Autogenous Vaccines Market: Market Sales (2020-2025) & (K Units)
Figure 21. Global Swine Autogenous Vaccines Sale Market Share by Application (2024)
Figure 22. Global Swine Autogenous Vaccines Revenue Market Share by Application in 2025
Figure 23. Swine Autogenous Vaccines Sales by Company in 2025 (K Units)
Figure 24. Global Swine Autogenous Vaccines Sales Market Share by Company in 2025
Figure 25. Swine Autogenous Vaccines Revenue by Company in 2025 ($ millions)
Figure 26. Global Swine Autogenous Vaccines Revenue Market Share by Company in 2025
Figure 27. Global Swine Autogenous Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Swine Autogenous Vaccines Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Swine Autogenous Vaccines Sales 2020-2025 (K Units)
Figure 30. Americas Swine Autogenous Vaccines Revenue 2020-2025 ($ millions)
Figure 31. APAC Swine Autogenous Vaccines Sales 2020-2025 (K Units)
Figure 32. APAC Swine Autogenous Vaccines Revenue 2020-2025 ($ millions)
Figure 33. Europe Swine Autogenous Vaccines Sales 2020-2025 (K Units)
Figure 34. Europe Swine Autogenous Vaccines Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Swine Autogenous Vaccines Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Swine Autogenous Vaccines Revenue 2020-2025 ($ millions)
Figure 37. Americas Swine Autogenous Vaccines Sales Market Share by Country in 2025
Figure 38. Americas Swine Autogenous Vaccines Revenue Market Share by Country (2020-2025)
Figure 39. Americas Swine Autogenous Vaccines Sales Market Share by Type (2020-2025)
Figure 40. Americas Swine Autogenous Vaccines Sales Market Share by Application (2020-2025)
Figure 41. United States Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Swine Autogenous Vaccines Sales Market Share by Region in 2025
Figure 46. APAC Swine Autogenous Vaccines Revenue Market Share by Region (2020-2025)
Figure 47. APAC Swine Autogenous Vaccines Sales Market Share by Type (2020-2025)
Figure 48. APAC Swine Autogenous Vaccines Sales Market Share by Application (2020-2025)
Figure 49. China Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. India Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Swine Autogenous Vaccines Sales Market Share by Country in 2025
Figure 57. Europe Swine Autogenous Vaccines Revenue Market Share by Country (2020-2025)
Figure 58. Europe Swine Autogenous Vaccines Sales Market Share by Type (2020-2025)
Figure 59. Europe Swine Autogenous Vaccines Sales Market Share by Application (2020-2025)
Figure 60. Germany Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61. France Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Swine Autogenous Vaccines Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Swine Autogenous Vaccines Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Swine Autogenous Vaccines Sales Market Share by Application (2020-2025)
Figure 68. Egypt Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Swine Autogenous Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Swine Autogenous Vaccines in 2025
Figure 74. Manufacturing Process Analysis of Swine Autogenous Vaccines
Figure 75. Industry Chain Structure of Swine Autogenous Vaccines
Figure 76. Channels of Distribution
Figure 77. Global Swine Autogenous Vaccines Sales Market Forecast by Region (2026-2031)
Figure 78. Global Swine Autogenous Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Swine Autogenous Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Swine Autogenous Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Swine Autogenous Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Swine Autogenous Vaccines Revenue Market Share Forecast by Application (2026-2031)